Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar.
Condition: Colorectal Cancer Intervention: Drug: Pyrotinib Sponsor: Shanghai Changzheng Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials